Pancreatic Cancer Clinical Trials in Los Angeles

Showing 61-80 of 113 trials

Contrast Enhanced Endoscopic Ultrasound in Pancreas Lesions

NCT04324294

The purpose of this study is to determine whether quantitative contrast-enhanced endoscopic ultrasound (CE-EUS) improves the evaluation of pancreas tumors and precursor lesions, including cysts, compared to conventional endoscopic ultrasound.

PancreatitisPancreas CancerPancreas Cyst

Cedars-Sinai Medical Center200 participantsStarted Feb 2020

Los Angeles, California, United States

COMPLETEDPhase 3< 1 mile

Study Evaluating Efficacy and Safety of FFX Versus Combination of CPI-613 With mFFX in Patients With Metastatic Adenocarcinoma of the Pancreas

NCT03504423

A prospective, multicenter, open label, randomized phase III study to evaluate efficacy and safety of FFX versus CPI-613 + mFFX in patients with metastatic adenocarcinoma of the pancreas with age range of 18 to 75 years

Pancreatic Cancer Metastatic

Cornerstone Pharmaceuticals528 participantsStarted Nov 2018

Gilbert, Arizona, United States • Tucson, Arizona, United States • Duarte, California, United States +71 more locations

Contrast Enhanced Endoscopic Ultrasound in Pancreas Lesions

Study Evaluating Efficacy and Safety of FFX Versus Combination of CPI-613 With mFFX in Patients With Metastatic Adenocarcinoma of the Pancreas

Pancreatic Cancer Trials in Other Cities

Study Evaluating GZ17-6.02 in Patients With Advanced Solid Tumors or in Combination With Capecitabine in Metastatic Hormone Receptor Positive Breast Cancer

Stereotactic MRI-guided On-table Adaptive Radiation Therapy (SMART) for Locally Advanced Pancreatic Cancer

Study of Nanoliposomal Irinotecan (Nal-IRI)-Containing Regimens Versus Nab-paclitaxel Plus Gemcitabine in Patients With Previously Untreated, Metastatic Pancreatic Adenocarcinoma

S0727 Gemcitabine Hydrochloride and Erlotinib Hydrochloride With or Without Monoclonal Antibody Therapy in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery

Selumetinib Sulfate in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer With KRAS G12R Mutations

Study of Onivyde and 5-FU in Combination With Xilonix for Pancreatic Cancer With Cachexia

Study of Pegilodecakin (LY3500518) With FOLFOX Compared to FOLFOX Alone Second-line Tx in Participants With Metastatic Pancreatic Cancer

Veliparib in Combination With Gemcitabine and Intensity Modulated Radiation Therapy in Patients With Pancreatic Cancer

Immunotherapy Study for Surgically Resected Pancreatic Cancer

Vaccine Study for Surgically Resected Pancreatic Cancer

A Multi-Center Study of Ibrutinib in Combination With MEDI4736 in Subjects With Relapsed or Refractory Solid Tumors

AdV-tk Therapy With Surgery and Chemoradiation for Pancreas Cancer (PaTK01)

Study of Safety and Efficacy of Ribociclib and Trametinib in Patients With Metastatic or Advanced Solid Tumors

Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung Cancers

U01-Biomarkers for Noninvasive and Early Detection of Pancreatic Cancer

Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene

Masitinib in Combination With Gemcitabine for Treatment of Patients With Advanced/Metastatic Pancreatic Cancer

A Phase 2 Study of LY2495655 in Participants With Pancreatic Cancer

Other Conditions in Los Angeles